期刊
CLEVELAND CLINIC JOURNAL OF MEDICINE
卷 71, 期 7, 页码 551-560出版社
CLEVELAND CLINIC
DOI: 10.3949/ccjm.71.7.551
关键词
-
Toxic chemotherapeutic agents are slowly being supplemented by a new generation of drugs that recognize specific targets in or on cancer cells. Although these molecular and genetic approaches are in their infancy, they hold the promise of more effective therapies with markedly fewer side effects. Several targeted agents are already approved by the US Food and Drug Administration (FDA) for use in malignancies, and numerous others are in clinical trials.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据